Ginsenoside Rh2 Ameliorates Doxorubicin-Induced Senescence Bystander Effect in Breast Carcinoma Cell MDA-MB-231 and Normal Epithelial Cell MCF-10A

The anthracycline antibiotic doxorubicin is commonly used antineoplastic drug in breast cancer treatment. Like most chemotherapy, doxorubicin does not selectively target tumorigenic cells with high proliferation rate and often causes serve side effects. In the present study, we demonstrated the cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Hou, Jin-Gang, Jeon, Byeong-Min, Yun, Yee-Jin, Cui, Chang-Hao, Kim, Sun-Chang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429443/
https://www.ncbi.nlm.nih.gov/pubmed/30871042
http://dx.doi.org/10.3390/ijms20051244

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429443/
https://www.ncbi.nlm.nih.gov/pubmed/30871042
http://dx.doi.org/10.3390/ijms20051244

Ejemplares similares